Lion's Mane
Best-in-class: Lion's Mane
A medicinal mushroom that stimulates Nerve Growth Factor (NGF), supporting neuron health, memory and mood — a favorite natural nootropic.
Lion's Mane quick facts
| Suggested dose | 500–1,000 mg (or more) of a fruiting-body extract daily. |
| How often | Daily |
| Who it's for | Memory, focus, mood and nerve-health support. |
| Best-in-class brand | Lion's Mane |
Mechanistically one of the most interesting things on the shelf and one of the most overclaimed. The honest position is that the NGF story is well demonstrated in the lab and the human evidence is thin — that's not a reason to dismiss it, it's a reason not to promise anything. If you try it, the extract type matters more than the dose: a fruiting-body-only product misses the erinacines entirely. Give it two to three months, because nothing acting through nerve growth works in a week.
How Lion's Mane actually works
Two separate compound families do the work, and they're in different parts of the mushroom. Hericenones are in the fruiting body; erinacines are in the mycelium and are the ones small enough to cross the blood-brain barrier. Both stimulate nerve growth factor synthesis in nerve cells — NGF supports the survival, myelination and branching of neurons. The important caveat is that most of this is cell and rodent work; the human trials are small and short, and none of them measured NGF in living human brains. The mechanism is real, the extrapolation to human cognition is not yet earned.
Where to get Lion's Mane
Find Lion's Mane on iHerb →The evidence for Lion's Mane
Graded by what exists behind each claim.
✅ Clinically validated
- Small RCTs show improved cognition in mild impairment and reduced anxiety/depression scores.
- Stimulates NGF and supports nerve regeneration in lab/animal models.
📊 Correlative data
- Traditional cognitive/nerve use aligns with the NGF findings.
🧪 Theoretical / extrapolated benefits
- Nerve-regeneration and neuroprotection claims are exciting but human trials are still small.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Lion's Mane actually does
Two different families of compounds carry the nerve-growth claim, they are made in different parts of the fungus, and conflating them is how this product is sold. Hericenones are aromatic compounds found in the fruiting body — the white mushroom itself. Erinacines are cyathane diterpenoids found in the mycelium, the thread-like growth phase. Both are reported to stimulate nerve growth factor synthesis in cell systems. They are structurally unrelated and they are not in the same material.
The molecular route is indirect, and that indirectness is a constraint rather than a detail. Nerve growth factor is a protein of about 26 kilodaltons. It does not cross the blood-brain barrier and it is not what a capsule delivers. The proposal is that a small molecule crosses instead and induces local NGF expression in astrocytes, which then acts on TrkA-bearing neurons. So the compound has to be small, lipophilic and stable enough to reach brain tissue, which is precisely why erinacines attract more attention than hericenones.
Where erinacines come from has now been measured rather than assumed. Erinacine production and the expression of its biosynthetic genes vary with substrate and with tissue type in Hericium erinaceus Doar 2025. That is the single most useful mechanistic paper for a buyer: it says the amount of the candidate active compound depends on what the fungus was grown on and which part of it was harvested.
The preclinical case has been collected and it is a preclinical case. A systematic review of the role of erinacines in the neuroprotective effects of Hericium erinaceus covers preclinical models Spangenberg 2025. A systematic review restricted to animal and cell work is an honest label, and it locates exactly where the evidence currently stops.
There is a second, less glamorous mechanism with a more plausible route. The gut. Beta-glucans and other polysaccharides act locally on gut-associated immune tissue and on the mucosa without needing to be absorbed, and the evidence for Hericium in gastrointestinal disease is reviewed on that basis Gravina 2023. An effect on the gut does not require any of the blood-brain barrier reasoning above.
Cell, rodent, human — and where it stops
Cell and rodent work is extensive, the human work is small and recent, and the obstacle is that the human trials use a different material from the rodent ones.
In cells and animals. The erinacine literature in preclinical models has been systematically reviewed Spangenberg 2025. Those studies typically use erinacine-enriched mycelial preparations at doses established in rodents.
In people, twice, and both are small. A double-blind parallel-groups pilot study measured acute and chronic effects on cognitive function, stress and mood in young adults Docherty 2023, and a double-blind randomized placebo-controlled study measured acute effects of a standardized extract on cognition and mood in healthy younger adults Surendran 2025. Both describe themselves accurately as pilot or acute studies.
And the whole picture has been reviewed once as a supplement. A systematic review of the benefits, side effects and uses of Hericium erinaceus as a supplement is the appropriate reference for what is actually known about the product rather than about the molecule Menon 2025.
Here is the obstacle, and it is the form problem stated as a translation problem. The rodent neuroprotection work is largely on erinacine-containing mycelial material. The human cognitive work is on extracts and preparations that are not necessarily the same tissue. Since erinacine content depends on tissue and substrate Doar 2025, the chain from rodent to human is broken not by species but by the fact that the two arms were given different chemistry.
The second obstacle is that the human endpoints are healthy young adults. Cognitive improvement is hardest to demonstrate in people whose cognition is already normal, so a null result in that population is weak evidence of absence Docherty 2023 Surendran 2025, and a positive one is easy to over-read.
Lion's Mane — which form, and does it matter
Fruiting body and mycelium are different chemistry, and in the United States most of what is sold is the second one grown on grain. Mycelium is cultivated on a sterilized cereal substrate and harvested together with it, because separating fungal threads from the grain they have colonized is not practical at scale. The finished powder is therefore part fungus and part cereal, in a ratio the label does not state.
The measurement that makes this checkable now exists. Erinacine production and biosynthetic gene expression depend on substrate and on tissue type Doar 2025. That is a direct statement that where and how the fungus is grown changes how much of the candidate active compound it contains, which is exactly what a label cannot be trusted to imply.
The number on the panel is usually a polysaccharide percentage and it is the wrong number. A crude polysaccharide assay does not distinguish fungal beta-glucan from cereal alpha-glucan — that is, from starch. A mycelium-on-grain product can honestly report a high polysaccharide content that is largely the rice it grew on. Beta-glucan specifically, ideally with alpha-glucan reported alongside, is the pair of figures that separates a mushroom product from a cereal one.
So a buyer has two questions, and both have short answers. Which tissue — fruiting body or mycelium — and what is the beta-glucan figure. A vendor that answers both is selling a characterized product. The review of Hericium as a supplement is the place where the range of what is sold under the name is described Menon 2025.
Extraction chooses the fraction, as it does for every medicinal fungus. Beta-glucans are extracted by hot water; the terpenoids and aromatic compounds that carry the nerve-growth claim are not. A hot-water extract concentrates the gut-active fraction Gravina 2023 and leaves the neuroactive candidates behind, and only a dual extraction takes both. A product that names its solvent has told the reader which half they bought.
What would have to be true, and how you would know it was not
1. Predict any cognitive effect shows up on processing speed and not on memory, and shows up acutely. The randomized acute study measured cognition and mood after a single standardized dose Surendran 2025. Prediction: reaction time and sustained-attention tasks move within hours if anything does, while delayed recall does not change for weeks or at all Docherty 2023.
2. Predict serum nerve growth factor does not move. This is the prediction that cuts hardest against the marketing. NGF acts locally in tissue; a circulating concentration is a poor reflection of brain expression, and the preclinical mechanism does not predict a systemic rise Spangenberg 2025. Anybody claiming a measured NGF increase from a supplement should be asked which compartment they measured.
3. Predict the gastrointestinal effect is easier to detect than the cognitive one. The gut evidence is reviewed on its own Gravina 2023, the mechanism does not require absorption, and symptom diaries are more sensitive than cognitive batteries in small samples. Retest window is four to eight weeks.
4. Predict a fruiting-body product and a mycelium-on-grain product give different results at the same labeled dose. Because erinacine content tracks with tissue and substrate Doar 2025, matched-milligram comparison should diverge. If it did not, the form section here would be wrong and the active compound would be something present in both.
5. Predict the assay result before buying. Ask a vendor for beta-glucan and alpha-glucan percentages. Prediction: mycelium-on-grain products report high total polysaccharide, low beta-glucan and high alpha-glucan, and most vendors will not have the figures at all. That absence is the answer.
What nobody has tested yet
Nobody has measured erinacine or hericenone content across on-market products. The determinants of erinacine content are now described Doar 2025 and no survey has applied that to what is on a shelf. Without it, no dose on any label can be connected to the preclinical literature Spangenberg 2025.
Nobody has run fruiting body against mycelium in a person. It is a two-arm trial with a cognitive or gastrointestinal endpoint and it would settle the central commercial dispute in this category. The existing human studies use one preparation each Docherty 2023 Surendran 2025.
Nobody has published human pharmacokinetics for either compound family. Whether an erinacine reaches human plasma at all, let alone brain tissue, is unmeasured. The entire nerve-growth argument rests on a step that has never been demonstrated in a person, and saying so is more useful than repeating the cell data.
And nobody has tested it in the population it is aimed at. The human trials recruit healthy younger adults Surendran 2025 Docherty 2023. Older adults with subjective cognitive complaints are who buys this, and the supplement review is explicit about how thin the evidence in that group is Menon 2025.
Lion's Mane — its own safety story, not its category's
The safety record is quiet and the systematic review that collects it says so, which is the right basis for the statement. Benefits, side effects and uses of Hericium erinaceus as a supplement have been reviewed together Menon 2025, and the reported adverse effects are predominantly gastrointestinal and skin-related rather than systemic.
The specific reaction to know about is dermatological. Contact dermatitis and reports of a rash following ingestion appear in the literature. A fungus is a common allergen class, and somebody with known mushroom allergy should treat this as the same category rather than as a nootropic.
The substrate is an undeclared part of the safety profile. A mycelium-on-grain product contains the grain. For somebody with a cereal allergy or on a strict gluten-free diet for celiac disease, whether the substrate was rice or wheat is a real question that the polysaccharide-percentage discussion above turns into a safety question as well as a value one Doar 2025.
The bleeding and glucose questions are theoretical here rather than documented. Fungal polysaccharides are frequently attributed antiplatelet and glucose-lowering activity as a class, and for this species the human data is not there to confirm or exclude it. The honest position is that anybody on an anticoagulant or on insulin is adding an uncharacterized variable, which is a reason to watch rather than a reason to panic.
And the real risk is what the product is being used instead of. The human cognitive evidence is two small studies in healthy young adults Docherty 2023 Surendran 2025 and a preclinical body of work in animals Spangenberg 2025. New or progressive cognitive symptoms are a reason for assessment, and nothing on this page is medical advice or diagnosis.
Sources read for this page
- Doar E. Influences of substrate and tissue type on erinacine production and biosynthetic gene expression in Hericium erinaceus. Fungal Biol Biotechnol 2025 · PMID 40181478
- Docherty S. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients 2023 · PMID 38004235
- Surendran G. Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. Front Nutr 2025 · PMID 40276537
- Menon A. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr 2025 · PMID 40959699
- Spangenberg ET. Unveiling the role of erinacines in the neuroprotective effects of Hericium erinaceus: a systematic review in preclinical models. Front Pharmacol 2025 · PMID 40626304
- Gravina AG. Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases. World J Gastroenterol 2023 · PMID 37346156
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Something that can be marked wrong: a language app streak with an accuracy percentage, a piece of music you are learning, names at a weekly meeting. The nerve-growth-factor story is about learning and nerve health, so a learning task is the nearest observable, and feeling sharper is not one.
- How long before it means anything: Eight to twelve weeks. Its human trials are small and the reported effects build across that kind of window — nothing about a nerve-growth mechanism predicts a difference on day three.
- What will fool you: The product itself. Most of what is sold is mycelium grown on grain, which arrives in the capsule as largely grain starch rather than fruiting body, so a null result may be a verdict on the bottle and nothing else. Check the label says fruiting body before you conclude the mushroom does not work on you.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Lion's Mane — safety & side effects
- Well tolerated. Skin rash and GI upset are the usual reports; a small number of people describe itching, which is thought to be an immune effect.
- Reports of persistent sensory or mood changes after stopping exist in user communities but not in the trial literature. We mention it because it comes up constantly and pretending otherwise is not useful — the data to confirm or dismiss it does not exist.
- Mild antiplatelet activity; caution with anticoagulants and before surgery. Avoid with mushroom allergy.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
Build your foundation with Coach Cam
The full Supplement Vault — 371 products across 14 categories with clinical, correlative & theoretical evidence, plus my Thorne partner links — lives inside Skool alongside 278 peptides.
Join Skool — $10/mo →Bloodwork to run alongside Lion's Mane
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid disease imitates every cognitive complaint there is |
| Vitamin B12 | Deficiency causes fog long before it causes anemia |
| Methylmalonic Acid (MMA) | Catches the deficiency a normal B12 hides |
| Ferritin | Low iron flattens cognition at levels most labs call fine |
| Vitamin D (25-Hydroxy) | Commonly low, cheap to correct, associated with mood |
The Brain Fog & Cognition panel covers these in one order — 12 markers, $233.06 with the discount applied.
Check results you already have → · All 103 markers A–Z
Lion's Mane — frequently asked questions
What is Lion's Mane?
A medicinal mushroom that stimulates Nerve Growth Factor (NGF), supporting neuron health, memory and mood — a favorite natural nootropic.
What is the suggested dose of Lion's Mane?
500–1,000 mg (or more) of a fruiting-body extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
What are the researched benefits of Lion's Mane?
Small RCTs show improved cognition in mild impairment and reduced anxiety/depression scores.
Who is Lion's Mane for?
Memory, focus, mood and nerve-health support.
Where can I buy Lion's Mane?
Coach Cam sources Lion's Mane from vetted, top-rated brands on iHerb — use the buy link on this page.
Lion's Mane inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Lion's Mane is used for
Lion's Mane appears under 1 goal in the goal router.
Related Cognitive & Mood supplements
Where this goes next
Lion's Mane is the bdnf arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.